Diagnóstico UAL

What Diagnóstico UAL does

Diagnóstico UAL S.A.C. is a Peruvian medical technology distributor founded in 2000 and headquartered in Magdalena del Mar, Lima. The company imports and commercializes latest-generation diagnostic equipment, reagents, consumables, and software for blood banks, clinical laboratories, and molecular biology applications, serving over 40 healthcare institutions across Peru including Lima, Lambayeque, La Libertad, Piura, and Arequipa. Its portfolio spans automated immunohematology analyzers, the INTERCEPT Blood System for pathogen inactivation, comprehensive blood bank management software (e-Delphyn), and a suite of immunoassay and molecular diagnostic tests.

The company operates as the exclusive Peruvian representative of several global medtech brands: Cerus Corporation (INTERCEPT pathogen inactivation system), DiaSorin (LIAISON XL/MDX immunoassay and molecular analyzers, including COVID-19 serology and antigen tests), Grifols (Procleix Panther molecular testing platform, plasma-derived therapeutics), and Hemasoft (e-Delphyn blood bank software with HL7/ISBT 128 integration). It complements this equipment portfolio with the Inmulink remote validation tool, biometric donor identification, and supplementary modules for tissue, tumor, and human milk bank management.

Diagnóstico UAL generates revenue primarily through direct institutional sales of imported hardware, reagents, and consumables, supplemented by post-sale technical support and software implementation services. Its go-to-market combines an enterprise field sales motion targeting MINSA and ESSALUD public hospital networks and private healthcare providers, with event-driven engagement through blood donation campaigns and professional training events. Pricing is not publicly disclosed and operates almost entirely through institutional procurement and tenders rather than transactional channels.

Name

Diagnóstico UAL

Legal name

Diagnóstico UAL S.A.C.

Website

https://diagnosticoual.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

Diagnóstico UAL S.A.C. is a Peruvian medical technology distributor that imports and commercializes diagnostic equipment, reagents, and software for blood banks and clinical laboratories across Peru, serving public hospitals (MINSA, ESSALUD) and private healthcare providers.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Equipment Distribution

NAICS

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450), In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (62151)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH)

akta.pro secondary industries

Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

Keywords

• Medical diagnostic equipment
• Blood bank solutions
• Clinical laboratory supplies
• Pathogen inactivation systems
• Medical device distribution

Headquarters

HQ city

Lima

HQ country

Peru

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Distribution and Commercialization of Medical Diagnostic Products: Diagnóstico UAL imports and commercializes latest-generation diagnostic equipment, reagents, and software for blood banks, clinical laboratories, and molecular biology. Revenue is generated through direct sales of equipment, reagents, consumables, and related services to healthcare institutions and laboratories throughout Peru.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Diagnóstico UAL imports, distributes, and provides post-sale support for specialized medical diagnostic equipment, reagents, software, and consumables used by blood banks, clinical laboratories, and molecular biology facilities across Peru. It acts as the exclusive Peruvian representative for global suppliers including Cerus (INTERCEPT Blood System), DiaSorin (LIAISON XL/MDX analyzers and COVID-19 diagnostics), Grifols (Procleix Panther molecular testing and plasma-derived therapies), and Hemasoft (e-Delphyn blood bank management software), selling automated immunohematology systems, pathogen inactivation technology, serology and molecular diagnostic kits, and integrated laboratory and transfusion medicine software to public and private hospitals and laboratories.

Product overview

Diagnóstico UAL S.A.C. is a Peruvian company specializing in the importation and commercialization of medical diagnostic products and equipment. The company offers an integrated portfolio of blood bank and clinical laboratory solutions including: (1) Blood bank services featuring immunohematology, immuneserology, and pathogen inactivation using the INTERCEPT Blood System; (2) e-Delphyn software suite for blood bank and transfusion medicine management including modules for tissue banks, human milk banks, and transfusion safety; (3) DiaSorin diagnostic platforms and tests including LIAISON XL/MDX analyzers, SARS-CoV-2 serology (TrimericS IgG, S1/S2 IgG), antigen, and molecular tests; (4) Grifols products including Procleix Panther TMA molecular tests and Gamunex-C hyperimmune immunoglobulins. The company operates through a network of hospitals and clinics across Peru including MINSA, ESSALUD, and private healthcare providers.

Differentiator

Problem solved

Functional benefit

Products and services

• INTERCEPT Blood System

Quantifiable outcome

• A voluntary blood donor can save up to four lives per donation
• +1 more outcomes

Named customers11 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

Feature6 records

Partnerships

Four partnerships are on record, tiered core.

• Cerus CorporationcoreGTM or Marketing PartnerDiagnóstico UAL is the exclusive representative of Cerus Corporation (Nasdaq: CERS) in Peru. Cerus develops and commercializes the INTERCEPT Blood System for pathogen inactivation in platelets and plasma. Diagnóstico UAL promotes, distributes, and provides technical support for INTERCEPT products in Peru's blood bank market.
• DiaSorincoreGTM or Marketing PartnerDiagnóstico UAL is the exclusive representative of DiaSorin (FTSE MIB: DIA) in Peru. DiaSorin is a global leader in in vitro diagnostics, offering the LIAISON XL automated immunoassay platform and COVID-19 diagnostic solutions. Diagnóstico UAL distributes DiaSorin products across Peru's healthcare sector.
• GrifolscoreGTM or Marketing PartnerDiagnóstico UAL is the exclusive representative of Grifols (MCE: GRF; NASDAQ: GRFS) in Peru. Grifols is a global leader in plasma-derived protein therapies and diagnostic solutions. Diagnóstico UAL distributes Grifols products including diagnostic tests and plasma products in Peru.
• HemasoftcoreTechnology or IntegrationDiagnóstico UAL represents Hemasoft in Peru. Hemasoft develops e-Delphyn, a comprehensive blood bank and transfusion medicine management software suite, and Inmulink, a web-based remote validation tool for immunohematology. Diagnóstico UAL implements and supports Hemasoft's software solutions in Peruvian healthcare institutions.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Cerus Corporation: Developer of the INTERCEPT Blood System for pathogen inactivation in platelets and plasma. Diagnóstico UAL is its exclusive Peruvian channel; comparable as a blood-safety specialist that licenses its technology through regional distributors in international markets.
• Hemasoft: Provider of the e-Delphyn blood-bank management software suite and Inmulink remote validation tool that Diagnóstico UAL implements in Peru. A direct peer in transfusion-software delivery to blood-bank customers in international markets.

Broad incumbents

• Bio-Rad Laboratories: Global IVD and blood-bank products manufacturer with a deep Latin America presence. Competes with Diagnóstico UAL's principals (e.g., DiaSorin, Grifols) in immunohematology, blood typing reagents, and quality controls, and is a reference point for what global IVD/blood-bank incumbents do in the region.
• Hologic: Diagnostics and women's health company with blood-bank and molecular testing offerings sold in Latin America. A reference peer for the molecular diagnostics portion of Diagnóstico UAL's portfolio.
• Grifols: Global leader in plasma-derived therapies and blood-bank diagnostics, whose Procleix Panther and diagnostic portfolio Diagnóstico UAL distributes in Peru. Operates a worldwide commercial network including direct LATAM presence, making it both a supplier and a direct competitive reference in transfusion medicine.
• Werfen (Instrumentation Laboratory): Specialized diagnostics company with a strong blood-bank and hemostasis franchise (ACL TOP, GEM Premier). Closely comparable to the immunohematology and coagulation testing solutions Diagnóstico UAL distributes in Peru.
• DiaSorin: Global IVD leader whose LIAISON XL/MDX platforms and SARS-CoV-2 assays form part of Diagnóstico UAL's portfolio. As both a principal supplier and a vertically integrated diagnostics manufacturer with its own LATAM commercial teams, DiaSorin is a comparable blood-bank and clinical-diagnostics counterparty.
• Abbott Diagnostics: Global IVD leader with blood-bank screening, immunoassay, and molecular platforms active across Latin America. Comparable as a broad incumbent whose products compete for the same Peruvian hospital and blood-bank budgets.
• Roche Diagnostics: World's largest IVD company, with extensive immunohematology, clinical chemistry, and molecular diagnostics portfolios sold in Peru. Represents the global-incumbent competitive set that regional distributors like Diagnóstico UAL position against.

Regional players

• Medifarma: One of Peru's largest domestic pharmaceutical and medical-product distributors, serving hospitals and clinics nationwide. Comparable as a Peruvian-headquartered medical distribution company with public-sector and private-customer reach, though focused more on pharmaceuticals than IVD equipment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCNgKKh_mB5JbO2OBxO2Ze7w
• Facebookfacebook.com/diagnosticoual
• Instagraminstagram.com/diagnosticoualperu

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diagnóstico UAL